|Bid||40.12 x 100|
|Ask||0.00 x 0|
|Day's Range||55.77 - 56.91|
|52 Week Range||40.56 - 69.89|
|PE Ratio (TTM)||16.34|
|Earnings Date||May 2, 2018 - May 7, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||56.55|
MEDNAX, Inc. , today announced the acquisition of Children’s Eye Care, LLC, a private pediatric ophthalmology practice based in Kirkland, Wash.
Investment researcher Mark Roberts has made many successful short-sale recommendations over the years, but so far, Mednax ain’t one of them. On March 4, his Off Wall Street Consulting Group put a Sell on the shares of Mednax, which buys medical practices and strikes deals with hospitals for its doctors’ services. Mednax stock had risen 20% since mid-November, to $55, following the disclosure of a 7% holding by Elliott Associates, Paul Singer’s activist firm, which said it hoped to talk with the practice-management company about a possible sale.
American Renal Associates Holdings (ARA) is the largest dialysis services provider in the United States with an exclusive focus on joint venture partnerships with physicians. Of the three analysts covering American Renal Associate Holdings in March 2018, two analysts have given the stock a “strong buy” rating and one analyst has given it a “buy” rating. Of the four analysts covering Civitas Solutions (CIVI) in March 2018, two analysts have given the stock a “strong buy” rating, and two analysts have given it a “buy” rating.
ResMed (RMD) consistently invests and expands globally in high-growth markets like China, South Korea, India, Brazil and across the Eastern Europe belt.
Varian Medical (VAR) has a strong international presence and growing proton therapy market. However, intense competition adds to woes.
Cardiovascular Systems (CSII) to distribute limited editions of both 1.0-4.0mm Sapphire II PRO and 2.0-4.0mm Sapphire NC Plus non-compliant coronary balloons post the product launches in the market.
Veeva Systems (VEEV) continues to witness year-over-year growth on earnings and revenues backed by the company's consistent efforts in product innovation and launches via R&D.
Zacks.com highlights: Sally Beauty Holdings, HCA Healthcare, MEDNAX, Cimpress N.V. and FTI Consulting
Acadia Healthcare's (ACHC) fourth-quarter 2017 results gained on higher contribution from its facilities in the U.K. and the United States.
Zacks.com featured highlights include: Allegheny, MEDNAX, Broadridge, AllianceBernstein and Aaron???s
Clifton Robbins founded Blue Harbour Group in 2004, having previously served as managing member of General Atlantic Partners, LLC, a private equity firm, and as partner at Kohlberg Kravis Roberts & Co. Blue Harbour invests mainly in activist situations and, what differentiates it from other activist funds, is that Clifton Robbins invests only in companies […]
NEW YORK, NY / ACCESSWIRE / February 8, 2018 / MEDNAX, Inc. (NYSE: MD ) will be discussing their earnings results in their Q4 Earnings Call to be held on February 8, 2018 at 10:00 AM Eastern Time. To listen ...
The Sunrise, Florida-based company said it had profit of $1.46 per share. Earnings, adjusted for one-time gains and costs, came to 87 cents per share. The results topped Wall Street expectations. The average ...